This document outlines an electrolytes and acid-base disturbance workshop presented by Dr. Mohammed Abdel Gawad. It includes 8 cases covering disorders of sodium, potassium, calcium, magnesium, phosphorus, and acid-base balance. For each case, it provides background information on the patient's history, physical exam findings, and lab results. It then asks a multiple choice question testing the diagnosis or management of the electrolyte disturbance. The cases are intended to help participants learn about evaluating and treating common electrolyte and acid-base disorders.
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/i_bUFU-p43Q
Arabic Language version of this lecture is available at:
https://youtu.be/RaIP09m4XMY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/Nl2xKEmvRWk
Arabic Language version of this lecture is available at:
https://youtu.be/K14fWBNdEco
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/Ed5naxEDwnQ
Arabic Language version of this lecture is available at:
https://youtu.be/eYe0ORMdnaI
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of the lecture:
English Language version of this lecture is available at: https://youtu.be/-Ynxvhbcl7U
Arabic Language version of this lecture is available at: https://youtu.be/QpK_toctVlw
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/i_bUFU-p43Q
Arabic Language version of this lecture is available at:
https://youtu.be/RaIP09m4XMY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/Nl2xKEmvRWk
Arabic Language version of this lecture is available at:
https://youtu.be/K14fWBNdEco
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/Ed5naxEDwnQ
Arabic Language version of this lecture is available at:
https://youtu.be/eYe0ORMdnaI
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of the lecture:
English Language version of this lecture is available at: https://youtu.be/-Ynxvhbcl7U
Arabic Language version of this lecture is available at: https://youtu.be/QpK_toctVlw
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at: https://youtu.be/GaapP5vsLB0
Arabic Language version of this lecture is available at: https://youtu.be/L5ynJVpaPNM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Presentation given to our fellowship program about diabetic kidney disease.
2022 update discussing SGLT2i, MRA (e.g. finerenone), health economics and beyond
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/e7Ttp4VH0VI
Arabic Language version of this lecture is available at: https://youtu.be/7d5JkPPdHsU
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/NQMiLXb0AXk
Arabic Language version of this lecture is available at:
https://youtu.be/o_I9bzxcJoQ
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at: https://youtu.be/YT5IlPs6F0I
Arabic Language version of this lecture is available at: https://youtu.be/HUZt4ahXlxo
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/lvcXwE0fb-w
- Arabic version of this lecture is available at:
https://youtu.be/r-fG8bSCqZo
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/71ud0njUrFc
Arabic Language version of this lecture is available at:
https://youtu.be/s8dQwB76bFM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/AtiaKPIdzAQ
Arabic Language version of this lecture is available at:
https://youtu.be/2cwyPcRDGEY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Renal Replacement therapy (Dialytic Management) in AKI - Dr.GawadNephroTube - Dr.Gawad
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/NN9vyWjIPbE
Arabic Language version of this lecture is available at:
https://youtu.be/i-Qlf31Vd-Y
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/Zb6WISbvE2k
Arabic Language version of this lecture is available at:
https://youtu.be/4IvvrbC31Q4
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...NephroTube - Dr.Gawad
- Recorded videos of this lecture:
Arabic Language version of this lecture is available at:
https://youtu.be/8eePyMbbK_g
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/V3UGzJTwAWw
- Arabic version of this lecture is available at:
https://youtu.be/hGLaUde2ue4
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at: https://youtu.be/GaapP5vsLB0
Arabic Language version of this lecture is available at: https://youtu.be/L5ynJVpaPNM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Presentation given to our fellowship program about diabetic kidney disease.
2022 update discussing SGLT2i, MRA (e.g. finerenone), health economics and beyond
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/e7Ttp4VH0VI
Arabic Language version of this lecture is available at: https://youtu.be/7d5JkPPdHsU
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/NQMiLXb0AXk
Arabic Language version of this lecture is available at:
https://youtu.be/o_I9bzxcJoQ
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at: https://youtu.be/YT5IlPs6F0I
Arabic Language version of this lecture is available at: https://youtu.be/HUZt4ahXlxo
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/lvcXwE0fb-w
- Arabic version of this lecture is available at:
https://youtu.be/r-fG8bSCqZo
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/71ud0njUrFc
Arabic Language version of this lecture is available at:
https://youtu.be/s8dQwB76bFM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/AtiaKPIdzAQ
Arabic Language version of this lecture is available at:
https://youtu.be/2cwyPcRDGEY
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Renal Replacement therapy (Dialytic Management) in AKI - Dr.GawadNephroTube - Dr.Gawad
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/NN9vyWjIPbE
Arabic Language version of this lecture is available at:
https://youtu.be/i-Qlf31Vd-Y
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/Zb6WISbvE2k
Arabic Language version of this lecture is available at:
https://youtu.be/4IvvrbC31Q4
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Cardiorenal Syndrome (Clinical Implications and Treatment Strategies) - Dr. G...NephroTube - Dr.Gawad
- Recorded videos of this lecture:
Arabic Language version of this lecture is available at:
https://youtu.be/8eePyMbbK_g
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/V3UGzJTwAWw
- Arabic version of this lecture is available at:
https://youtu.be/hGLaUde2ue4
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Dr Neerav Goyal discusses the various aspects of acute liver failure that includes the criteria, pre transplant issues, critical care management, overall survival.
Stroke is the 2nd leading death associated disorder. It is also known as cerebrovascular disorder mainly caused by high blood cholesterol levels or rupture of cerebral arteries.
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
- Video recording of this lecture in English language: https://youtu.be/gnlRvJ1TTr8
- Video recording of this lecture in Arabic language: https://youtu.be/KdVvfP7JIFI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
- Video recording of this lecture in English language: https://www.youtube.com/watch?v=MA7nU5NWL2g&list=PLL7Q08IoVDSpg0VlGdvCHOHbXqMs0GFRe
- Video recording of this lecture in Arabic language: https://www.youtube.com/watch?v=FiWabzTPFqY&list=PLL7Q08IoVDSrVcm6SmppQyefL_Ub2-xGY
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
- Recorded video of this lecture is available at:
https://youtu.be/4MCu1C5xjvE
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Thrombotic Microangiopathy (TMA) in Adults and Acute Kidney Injury - Dr. GawadNephroTube - Dr.Gawad
- English version of this lecture is available at:
https://youtu.be/zrFm0hAZk2A
- Arabic version of this lecture is available at:
https://youtu.be/M_BV8WJVbx0
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/t7N2GSXhYwA
- Arabic version of this lecture is available at:
https://youtu.be/WzFZym9hDtQ
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at:
https://youtu.be/XRD-QqGFP18
- Arabic version of this lecture is available at:
https://youtu.be/c9PoavAtNKM
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Infection-related Glomerulonephritis (KDIGO 2021 Guidelines) - Dr. GawadNephroTube - Dr.Gawad
- English version of this lecture is available at:
https://youtu.be/qItQlXUC2-Q
- Arabic version of this lecture is available at:
https://youtu.be/goKWRFbA4uc
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version video of this lecture is available at:
https://youtu.be/z9P_1IiFR5I
- Arabic version video of this lecture is available at:
https://youtu.be/qmDeWgsAY9Q
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at: https://youtu.be/_Efu52kZRS4
- Arabic version of this lecture is available at: https://youtu.be/8eGHpjQIy3I
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- English version of this lecture is available at: https://youtu.be/WHu05hmExBY
- Arabic version of this lecture is available at: https://youtu.be/GIvZjcq2Eis
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Insights from the FIGARO-DKD and FIDELIO-DKD trials - Dr. GawadNephroTube - Dr.Gawad
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/kanEHVsStsI
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
Diabetes Mellitus Management in CKD (Clinical Tips) - Dr. GawadNephroTube - Dr.Gawad
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/h3HRvWGUj5A
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
- Recorded videos of this lecture:
English Language version of this lecture is available at:
https://youtu.be/_i1H_i3tOuw
Arabic Language version of this lecture is available at:
https://youtu.be/SYmZ9CmmN5g
- Visit our website for more lectures: www.NephroTube.com
- Subscribe to our YouTube channel: www.youtube.com/NephroTube
- Join our facebook group: www.facebook.com/groups/NephroTube
- Like our facebook page: www.facebook.com/NephroTube
- Follow us on twitter: www.twitter.com/NephroTube
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Electrolytes & Acid-Base Disturbance Workshop - Dr. Gawad
1. Electrolytes & Acid-Base Disturbance
Workshop
Mohammed Abdel Gawad MD, ESENeph
Lecturer of Nephrology, School of Medicine, NewGiza University
Founder of NephroTube.com
ISN Education SoMe Team Member
Co-chair of AFRAN Web/Media Committee
2. Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
3. History
• An 18-year-old man presents with the complaint of nocturia and polyuria. His 24-hour
urine volume is 4.2 L. He has no other medical history.
Physical
examination
• BP of 115/70 mmHg
• heart of 72 beats per minute
• He is afebrile
• The rest of the examination is unremarkable
Blood tests
• sodium, 130 mEq/L
• potassium, 3.9 mEq/L
• chloride, 95 mEq/L
• bicarbonate, 26 mEq/L
• BUN, 10 mg/dl
• creatinine, 0.8 mg/dl
Urine tests
• sodium, 11 mEq/L
• potassium, 20 mEq/L
• volume, 4.2 L/d
• osmolality, 90 mOsm/L
What is the most likely cause of his hyponatremia?
A. SIADH
B. Occult diuretic use
C. Hypothyroidism
D. Primary polydipsia
Case #1 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
5. Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
6. History
• A 75-year-old man with recently diagnosed pancreatic cancer and hypertension (on
lisinopril and chlorthalidone).
Physical
examination
• He is intermittently agitated and disoriented with infrequent seizures
• The BP is 140/85 mmHg, and the pulse rate is 85/min
• The remainder of examination is unremarkable
Blood tests
• sodium of 115 mEq/L
• potassium of 3.9 mEq/L
• BUN of 6 mg/dl
• creatinine of 0.8 mg/dl
• glucose of 106 mg/dl
• calcium of 9.0 mg/dl
• serum osmolality of 236mOsm/kg
Urine tests
• The urine osmolality is 380 mOsm/kg
• The urine sodium is 40 mEq/L, and the urine potassium is 30 mEq/L
In addition to fluid restriction and discontinuing chlorthalidone, what is the MOST next step in management?
A. No additional interventions
B. 3% saline to increase SNa+ 4–6 mEq/L
C. Tolvaptan
D. Furosemide plus intravenous isotonic saline with potassium chloride
Case #2 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2017-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
8. IV infusion of 150
ml 3% hypertonic
(2 ml/kg) in case
of obviously
deviant body
composition
20 min
check
serum Na
Maximum:
Repeat twice
Maximum:
5 mmol/l
increase
A. Improvement of
symptoms
→ Stop 3% infusion
B. No improvement
of symptoms
→ continue infusion
targeting general
rules of raising
serum Na
keep the i.v. line
open by infusing the
smallest feasible
volume of 0.9%
saline until cause-
specific treatment is
started
First-hour management:
Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
Hyponatremia - Management – Severe Symptoms
9. General rules – 0.9% or 3% NaCl infusion
Maximum correction limit (i.e. Stop infusion when)
10 mmol/l in the
first 24 h
8 mmol/l during
every 24 h
thereafter
130 mmol/l is
reached or
serum sodium
concentration
increases
10 mmol/l in
total
symptoms
improved
If the symptoms still have not improved, it is unlikely that the
symptoms are due to the hyponatremia and alternative
explanations should be sought
Handbook of Critical Care Nephrology. Chapter 19. 2021
Nephrol Dial Transplant (2014) 29 (Suppl. 2): ii1–ii39
10. Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
11. Case #3 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
History
• A 38-year-old woman entered the emergency department with weakness, frequent
urination (UOP; 8L/d), and increased thirst.
Physical
examination
• Heart rate of 80 beats per minute
• BP of 120/80 mmHg supine and 115/75 mmHg upright
• The rest of the examination was noncontributory.
Blood tests
• sodium, 156 mEq/L
• potassium, 3.7 mEq/L
• chloride, 123.0 mEq/L
• bicarbonate, 24.0 mEq/L
• creatinine, 0.9 mg/dl
• BUN, 22.0 mg/ dl
• glucose, 130 mg/dl
• calcium, 9.1 mg/dl.
Urine tests • Urine osmolality was 88 mmol/kg
Which ONE of the following would MOST likely reveal the cause of her electrolyte disorder?
A. Fluid deprivation test
B. Plasma cortisol assay
C. Serum thyroid-stimulating hormone assay
D. Estimation of urinary osmoles
15. Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
16. Case #4 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
History
• A 38-year-old man presents with a recent history of hypertension.
• He is referred to you for further evaluation. He is currently being treated with a CCB.
Physical
examination
• BP of 165/90 mmHg supine and standing
• Heart rate of 62 beats per minute
• The rest of the examination is unremarkable
Blood tests
• sodium, 138 mEq/L
• potassium, 2.9 mEq/L
• chloride, 100 mEq/L
• metabolic alkalosis
• BUN, 16 mg/dl
• creatinine, 0.9mg/dl.
Urine tests • Urine K/Cr ratio, 35
• Urine chloride, 35 mmol/L
At this point, which ONE of the following should be done?
A. Plasma aldosterone to renin ratio
B. Abdominal CT scan
C. 24-hour urinary aldosterone level
D. Thyroid function test
21. Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
22. Case #5 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2014-Bone 40th ESNT Congress, Dr. Mohammed Abdel Gawad
History
• A 56-year-old man was diagnosed with colon cancer 3 years ago and had successful
surgery and postoperative chemotherapy.
• He denies weight loss, abdominal pain, jaundice, confusion, constipation, or polyuria.
• The patient drinks three to four “health tonics” rich in calcium and several servings of
milk and calcium-fortified orange juice daily.
CT scan
• He now has a possible metastatic lesion of the liver that was seen on a recent
abdominal computed tomography (CT) scan.
Blood tests
• serum calcium, 12.5 mg/dl
• undetectable serum (PTH)
• serum PTHrP, normal
• serum 25(OH)D 288 ng/ml (N, 25–80 ng/ml),
• serum 1,25(OH)2D 72 pg/ml (N, 25–65 pg/ml)
Which ONE of the following is the MOST likely cause of this patient’s hypercalcemia?
A. Recurrent colon cancer-producing PTHrP
B. Bone metastases
C. Vitamin D intoxication
D. Sarcoidosis
E. Excess calcium intake
23.
24. Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
25. Case #6 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2012-Bone 40th ESNT Congress, Dr. Mohammed Abdel Gawad
History
• A 70-year-old man was admitted to the hospital after he had lost consciousness.
• He had a history of peptic ulcer disease, hypertension, and hyperlipidemia.
• He was treated with lisinopril, atorvastatin, and omeprazole.
ECG • Rapid supraventricular tachycardia
Blood tests
• hypomagnesemia
• hypocalcemia
• hypokalemia
Beside management of his electrolyte disturbances, which ONE of the following should be the next step?
A. Measure PTH.
B. Measure calcitonin.
C. Discontinue omeprazole.
D. Discontinue atorvastatin.
E. Measure the renin/aldosterone ratio.
26.
27. Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
28. History
• A 70-year-old man with recently diagnosed monoclonal Ig deposition disease is evaluated
for hyperphosphatemia.
• He began therapy with bortezomib, lenalidomide, and dexamethasone 2 days ago.
• His urine output has been normal, and he complains of fatigue.
Blood tests
• sodium of 136 mEq/L
• potassium of 4.2 mEq/L
• BUN of 25 mg/dl, creatinine of 1.3 mg/dl
• calcium of 9.1 mg/dl
• phosphorus of 6.6 mg/dl
• Normal LDH
• uric acid of 4.2 mg/dl
• leukocyte count of 4700/ml
• hemoglobin 9.6 of g/dl
• The serum IgG is 14,400 mg/dl
(reference range=600–1700 mg/dl)
• Serum free k-light chains, 1288 mg/dl
• serum free l-light chains are 2.16 mg/dl.
Which ONE of the following is the MOST likely cause of this man's hyperphosphatemia?
A. Tumor lysis syndrome
B. Decreased GFR
C. Elevated IgGk monoclonal protein
D. Rhabdomyolysis
Case #7 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2016-Bone 40th ESNT Congress, Dr. Mohammed Abdel Gawad
29.
30. Cases
• Case #1: Hyponatremia diagnosis
• Case #2: Hyponatremia treatment
• Case #3: Hypernatremia
• Case #4: Potassium disorder
• Case #5: Calcium disorder
• Case #6: Magnesium disorder
• Case #7: Phosphorus disorder
• Case #8: Acid-Base disorder
31. Case #8 Electrolytes, Acid-Base Disturbance Workshop
Reference: Modified from NephSap-2013-Fluids 40th ESNT Congress, Dr. Mohammed Abdel Gawad
History
• A 25-year-old woman with recurrent kidney stones.
• She reports intermittent episodes of constipation
alternating with diarrhea.
Physical
examination
• BP is 106/70 mmHg
• The remainder of the examination is normal
Blood tests
• Na 137 mEq/L
• K 3.1 mEq/L
• Cl 114 mEq/L
• HCO3 11 mEq/L
• BUN 13
mg/dl
• creatinine
1.2 mg/dl
• Venous blood gas
metabolic acidosis
Urine tests • Na 60 mEq/L
• K 50 mEq/L
• Cl 42 mEq/L. • pH 6.5
• specific gravity 1.014
Which ONE of the following is the MOST likely diagnosis?
A. Proximal RTA
B. Barium sulfide toxicity
C. Type I distal RTA
D. Toluene toxicity
32. Metabolic Acidosis
Calculate Anion Gap
AG
HCO3-
Cl-
Na + K
AG
HCO3-
Cl-
Na + K
Wide anion gap
Normo-cholremic
Acidosis
Na + K
AG
HCO3-
Cl-
Cl-
Normal anion gap
Hyper-cholremic
Acidosis
Corrected Anion Gap: anion gap is decreased by 2.5
mmol/l for each 1 g/dl decrease in the serum albumin
concentration below normal.
AG = (Na + K) – (Cl + HCO3) = 16 ± 4 mmol/l
AG = (Na) – (Cl + HCO3) = 12 ± 4 mmol/l
35. 2- b- if normal anion gap → calculate urinary AG
4- uretrosigmoid-ostomy
NH4Cl
36. 2- b- if normal anion gap → calculate urinary AG
4- uretrosigmoid-ostomy
NH4Cl
urine AG = u[Na + K] – u[Cl]
If –ve: so the loss is non renal
If zero or +ve: so the loss is renal